207 related articles for article (PubMed ID: 9624539)
21. Host-directed therapies for bacterial and viral infections.
Kaufmann SHE; Dorhoi A; Hotchkiss RS; Bartenschlager R
Nat Rev Drug Discov; 2018 Jan; 17(1):35-56. PubMed ID: 28935918
[TBL] [Abstract][Full Text] [Related]
22. Versatile polymer-based strategies for antibacterial drug delivery systems and antibacterial coatings.
You K; Gao B; Wang M; Wang X; Okoro KC; Rakhimbekzoda A; Feng Y
J Mater Chem B; 2022 Feb; 10(7):1005-1018. PubMed ID: 35089304
[TBL] [Abstract][Full Text] [Related]
23. Current guidelines on the use of antibacterial drugs in patients with malignancies.
Mayer KH; DeTorres OH
Drugs; 1985 Mar; 29(3):262-79. PubMed ID: 3886354
[TBL] [Abstract][Full Text] [Related]
24. [The antibacterial therapy of infectious lung lesions].
Martsinovskiĭ VIu; Sil'vestrov VP; Semin SN
Ter Arkh; 1990; 62(9):8-15. PubMed ID: 2281414
[No Abstract] [Full Text] [Related]
25. [New antibacterial agents].
Vaara M; Saxén H
Duodecim; 1999; 115(20):2259-64. PubMed ID: 11973930
[No Abstract] [Full Text] [Related]
26. [Bacterial infections. Progress and new prospects in chemo-antibiotic therapy].
Olivieri A; Fostini R; Xerri L; Recchia G
Clin Ter; 1991 Jan; 136(1):53-61. PubMed ID: 1826874
[TBL] [Abstract][Full Text] [Related]
27. Opportunities for the development of novel therapies based on host-microbial interactions.
Santos PC; Teixeira MM; Souza DG
Pharmacol Res; 2016 Oct; 112():68-83. PubMed ID: 27107789
[TBL] [Abstract][Full Text] [Related]
28. Cationic peptides: effectors in innate immunity and novel antimicrobials.
Hancock RE
Lancet Infect Dis; 2001 Oct; 1(3):156-64. PubMed ID: 11871492
[TBL] [Abstract][Full Text] [Related]
29. The management of odontogenic infections. A rationale for appropriate chemotherapy.
Baker KA; Fotos PG
Dent Clin North Am; 1994 Oct; 38(4):689-706. PubMed ID: 7805942
[TBL] [Abstract][Full Text] [Related]
30. [Advances in the research of treating multi-drug resistant bacterial infections].
Peng Y; Fu YX
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):539-41. PubMed ID: 27647070
[TBL] [Abstract][Full Text] [Related]
31. Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment.
Zhang W; Hu E; Wang Y; Miao S; Liu Y; Hu Y; Liu J; Xu B; Chen D; Shen Y
Int J Nanomedicine; 2021; 16():6141-6156. PubMed ID: 34511911
[TBL] [Abstract][Full Text] [Related]
32. [Effect of contemporary chemotherapeutic drugs on phagocyte activity and the immune response].
Nikitin AV; Navashin PS; Smolkina TV
Antibiot Khimioter; 1996; 41(7-8):49-56. PubMed ID: 8999764
[No Abstract] [Full Text] [Related]
33. The responsibility of the infectious disease community for the optimal use of antimicrobial agents.
Kunin CM
J Infect Dis; 1985 Mar; 151(3):388-98. PubMed ID: 3882848
[TBL] [Abstract][Full Text] [Related]
34. An analysis of FDA-approved drugs for infectious disease: antibacterial agents.
Kinch MS; Patridge E; Plummer M; Hoyer D
Drug Discov Today; 2014 Sep; 19(9):1283-7. PubMed ID: 25043770
[TBL] [Abstract][Full Text] [Related]
35. The choice of antibacterial drugs.
Med Lett Drugs Ther; 1992 May; 34(871):49-56. PubMed ID: 1584115
[No Abstract] [Full Text] [Related]
36. Recombinant probiotics with antimicrobial peptides: a dual strategy to improve immune response in immunocompromised patients.
Mandal SM; Silva ON; Franco OL
Drug Discov Today; 2014 Aug; 19(8):1045-50. PubMed ID: 24881782
[TBL] [Abstract][Full Text] [Related]
37. Anti-infective quinone derivatives of recent patents.
Koyama J
Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):113-25. PubMed ID: 18221140
[TBL] [Abstract][Full Text] [Related]
38. [Antibiotheraphy in the 21st century, antibacterials for the second decade. Posibilities or realities in the future?].
García-Sánchez JE; García-Merino E; Martín-del-Rey A; García-Sánchez E
Rev Esp Quimioter; 2012 Jun; 25(2):100-21. PubMed ID: 22707099
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial peptides: new candidates in the fight against bacterial infections.
Toke O
Biopolymers; 2005; 80(6):717-35. PubMed ID: 15880793
[TBL] [Abstract][Full Text] [Related]
40. [Antibacterial and immunomodulating therapy of respiratory tract diseases].
Sil'vestrov VP; Karaulov AV
Ter Arkh; 1983; 55(3):3-9. PubMed ID: 6344301
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
